Lifestyle October 30, 2026 at 1:22 PM

STAT+: Pharmalittle: We’re reading about AstraZeneca cost-cutting, Sun Pharma facility problems, and more

STAT News

AstraZeneca has launched a three-year cost-cutting program that aims to slice off $1.5 billion a year, with the savings reinvested in R&D

Excerpt from STAT News.

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical ind…

The Michael Kors and Jimmy Choo owner beat expectations for the second quarter.

Curated news from 12 countries and 10 languages. Coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play